Inflammatory response and chemokine expression in the white matter corpus callosum and gray matter cortex region during cuprizone-induced demyelination

Journal of Molecular Neuroscience

Volumn 48, Issue 1, 2012, Pages 66-76

  Buschmann, J P ^a   Berger, K ^a   Awad, H ^a   Clarner, T ^a   Beyer, C ^a   Kipp, M ^a,b,c  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Chemokines; CNS; Cuprizone; Demyelination; Inflammation; Multiple sclerosis

Indexed keywords

CHEMOKINE; CUPRIZONE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ASTROCYTE; ASTROCYTOSIS; BRAIN CORTEX; CELL ACTIVATION; CELL STRESS; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATION; GRAY MATTER; INFLAMMATION; MALE; MICROGLIA; MOUSE; NONHUMAN; OLIGODENDROGLIA; PROTEIN EXPRESSION; REVIEW; TELENCEPHALON; WHITE MATTER;

ANIMALS; CEREBRAL CORTEX; CHEMOKINE CCL2; CHEMOKINE CCL3; CORPUS CALLOSUM; CUPRIZONE; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; ENCEPHALITIS; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; MONOAMINE OXIDASE INHIBITORS; MULTIPLE SCLEROSIS; OLIGODENDROGLIA;

EID: 84865111743     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-012-9773-x     Document Type: Review

References (45)

1. Acs P, Kipp M, Norkute A, Johann S, Clarner T, Braun A et al (2009) 17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice. Glia 57(8):807-814
2. Baertling F, Kokozidou M, Pufe T, Clarner T, Windoffer R, Wruck CJ et al (2010) ADAM12 is expressed by astrocytes during experimental demyelination. Brain Res 1326:1-14
3. Baggiolini M (1998) Chemokines and leukocyte traffic. Nature 392(6676):565-568 (Pubitemid 28207705)
4. Barnett MH, Prineas JW (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55(4):458-468 (Pubitemid 38391962)
5. Bitsch A, Kuhlmann T, Stadelmann C, Lassmann H, Lucchinetti C, Bruck W (2001) A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann Neurol 49(6):793-796 (Pubitemid 32530247)
6. Bo L, Vedeler CA, Nyland H, Trapp BD, Mork SJ (2003) Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 9(4):323-331 (Pubitemid 36958014)
7. Braun A, Dang J, Johann S, Beyer C, Kipp M (2009) Selective regulation of growth factor expression in cultured cortical astrocytes by neuro-pathological toxins. Neurochem Int 55(7):610-618
8. Breij EC, Brink BP, Veerhuis R, van den Berg C, Vloet R, Yan R et al (2008) Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann Neurol 63(1):16-25 (Pubitemid 351240547)
9. Clarner T, Parabucki A, Beyer C, Kipp M (2011) Corticosteroids impair remyelination in the corpus callosum of cuprizone-treated mice. J Neuroendocrinol 23:601-611
10. Dang J, Mitkari B, Kipp M, Beyer C (2011) Gonadal steroids prevent cell damage and stimulate behavioral recovery after transient middle cerebral artery occlusion in male and female rats. Brain Behav Immun 25(4):715-726
11. De Groot CJ, Bergers E, Kamphorst W, Ravid R, Polman CH, Barkhof F et al (2001) Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. Brain 124(Pt 8):1635-1645 (Pubitemid 32726776)
12. Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M et al (2009) The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 132(Pt 5):1175-1189
13. Gay FW (2006) Early cellular events in multiple sclerosis. Intimations of an extrinsic myelinolytic antigen. Clin Neurol Neurosurg 108(3):234-240
14. Geurts JJ, Barkhof F (2008) Grey matter pathology in multiple sclerosis. Lancet Neurol 7(9):841-851
15. Geurts JJ, Bo L, Roosendaal SD, Hazes T, Daniels R, Barkhof F et al (2007) Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol 66(9):819-827 (Pubitemid 47360957)
16. Glabinski AR, Tani M, Strieter RM, Tuohy VK, Ransohoff RM (1997) Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am J Pathol 150(2):617-630 (Pubitemid 27073789)
17. Groebe A, Clarner T, Baumgartner W, Dang J, Beyer C, Kipp M (2009) Cuprizone treatment induces distinct demyelination, astrocytosis, and microglia cell invasion or proliferation in the mouse cerebellum. Cerebellum 8(3):163-174
18. Hesse A, Wagner M, Held J, Bruck W, Salinas-Riester G, Hao Z et al (2010) In toxic demyelination oligodendroglial cell death occurs early and is FAS independent. Neurobiol Dis 37(2):362-369
19. Hoffman GE, Le WW, Murphy AZ, Koski CL (2001) Divergent effects of ovarian steroids on neuronal survival during experimental allergic encephalitis in Lewis rats. Exp Neurol 171(2):272-284 (Pubitemid 32955288)
20. Karpus WJ, Kennedy KJ (1997) MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation. J Leukoc Biol 62(5):681-687 (Pubitemid 27519780)
21. Karpus WJ, Ransohoff RM (1998) Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis. J Immunol 161(6):2667-2671 (Pubitemid 28425682)
22. Karpus WJ, Lukacs NW, McRae BL, Strieter RM, Kunkel SL, Miller SD (1995) An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J Immunol 155(10):5003-5010
23. Kipp M, Norkute A, Johann S, Lorenz L, Braun A, Hieble A et al (2008) Brain-region-specific astroglial responses in vitro after LPS exposure. J Mol Neurosci 35(2):235-243
24. Kipp M, Clarner T, Dang J, Copray S, Beyer C (2009) The cuprizone animal model: new insights into an old story. Acta Neuropathol 118(6):723-736
25. Kipp M, Gingele S, Pott F, Clarner T, van der Valk P, Denecke B et al (2011a) BLBP-expression in astrocytes during experimental demyelination and in human multiple sclerosis lesions. Brain Behav Immun 25:1554-1568
26. Kipp M, Norkus A, Krauspe B, Clarner T, Berger K, van der Valk P et al (2011b) The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis. Inflamm Res 60:723-726
27. Kipp M, Clarner C, Gingele S, Pott F, Amor S, van der Valk P et al (2011c) Brain lipid binding protein (FABP7) as modulator of astrocyte function. Physiol Res 60:S49-S60
28. Lucchinetti CF, Popescu BF, Bunyan RF, Moll NM, Roemer SF, Lassmann H et al (2011) Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 365(23):2188-2197
29. Luster AD (1998) Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 338(7):436-445 (Pubitemid 28135672)
30. Marik C, Felts PA, Bauer J, Lassmann H, Smith KJ (2007) Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? Brain 130(Pt 11):2800-2815 (Pubitemid 350033973)
31. McMahon EJ, Cook DN, Suzuki K, Matsushima GK (2001) Absence of macrophage-inflammatory protein-1alpha delays central nervous system demyelination in the presence of an intact blood-brain barrier. J Immunol 167(5):2964-2971 (Pubitemid 32768933)
32. McManus C, Berman JW, Brett FM, Staunton H, Farrell M, Brosnan CF (1998) MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study. J Neuroimmunol 86(1):20-29 (Pubitemid 28293946)
33. Norkute A, Hieble A, Braun A, Johann S, Clarner T, Baumgartner W et al (2009) Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus. J Neurosci Res 87(6):1343-1355
34. Okada M, Makino A, Nakajima M, Okuyama S, Furukawa S, Furukawa Y (2010) Estrogen stimulates proliferation and differentiation of neural stem/progenitor cells through different signal transduction pathways. Int J Mol Sci 11(10):4114-4123
35. Patel JR, McCandless EE, Dorsey D, Klein RS (2010) CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination. Proc Natl Acad Sci U S A 107(24):11062-11067
36. Peterson JW, Bo L, Mork S, Chang A, Trapp BD (2001) Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 50(3):389-400 (Pubitemid 32848742)
37. Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30(9):e36
38. Skripuletz T, Lindner M, Kotsiari A, Garde N, Fokuhl J, Linsmeier F et al (2008) Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am J Pathol 172(4):1053-1061 (Pubitemid 351520001)
39. Sozzani S, Locati M, Allavena P, Van Damme J, Mantovani A (1996) Chemokines: a superfamily of chemotactic cytokines. Int J Clin Lab Res 26(2):69-82 (Pubitemid 26310342)
40. Szczucinski A, Losy J (2007) Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies. Acta Neurol Scand 115(3):137-146 (Pubitemid 46219205)
41. van der Valk P, Amor S (2009) Preactive lesions in multiple sclerosis. Curr Opin Neurol 22(3):207-213
42. van der Valk P, De Groot CJ (2000) Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. Neuropathol Appl Neurobiol 26(1):2-10 (Pubitemid 30145301)
43. van Horssen J, Brink BP, de Vries HE, van der Valk P, Bo L (2007) The blood-brain barrier in cortical multiple sclerosis lesions. J Neuropathol Exp Neurol 66(4):321-328 (Pubitemid 46559025)
44. van Noort JM, van den Elsen PJ, van Horssen J, Geurts JJ, van der Valk P, Amor S (2011) Preactive multiple sclerosis lesions offer novel clues for neuroprotective therapeutic strategies. CNS Neurol Disord Drug Targets 10(1):68-81
45. Zou LP, Pelidou SH, Abbas N, Deretzi G, Mix E, Schaltzbeerg M et al (1999) Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats. J Neuroimmunol 98(2):168-175 (Pubitemid 29317543)